An unexpected mechanism. Clinicians use 5-fluorouracil (5-FU) as a first-line drug for colon, rectal, and pancreatic cancers. It's usually given in combination with oxaliplatin or irinotecan, ...

An unexpected mechanism. Clinicians use 5-fluorouracil (5-FU) as a first-line drug for colon, rectal, and pancreatic cancers. It’s usually given in combination with oxaliplatin or irinotecan, ...

For 15 years, gemcitabine remained the standard first-line agent for patients with normal bilirubin levels and a good performance status (PS), but if the treatment is well tolerated, its efficacy as a ...

COI Statement. L.A.C. and S.D. are coinventors on a filed patent for the use of calcipotriol plus 5-fluorouracil for the treatment of precancerous skin lesions (PCT/US2015/049434).

Fluorouracil (5-FU) is a common chemotherapy drug that can be administered as an injection or a cream, depending on the use. Medicare typically covers it when needed for cancer treatment.

Fluorouracil (5-FU) is a type of chemotherapy. Original Medicare (parts A or B) should cover Fluorouracil when needed to treat cancer.

No dose of fluorouracil has been proven safe for patients with complete DPD deficiency. Patients with partial DPD deficiency may also be at increased risk; data regarding an appropriate dose for ...

A randomized phase II study of gemcitabine and nab-paclitaxel compared with 5-fluorouracil, leucovorin, and liposomal irinotecan in older patients with treatment-naïve metastatic pancreatic cancer ...